SYSTANE® PRO vs. MIEBO™ in Dry Eye Disease

Summary

This is a prospective, randomized, double-masked, multi-site clinical trial designed to compare the efficacy of SYSTANE® PRO (Alcon Laboratories, Inc.) to MIEBO™ (Bausch + Lomb) in treating symptoms of evaporative dry eye disease (DED). The primary goal is to determine whether SYSTANE® PRO is non-inferior to MIEBO™ after one month of treatment, based on change in Ocular Surface Disease Index (OSDI) scores.

Timeline

Start

2026-02-18

Primary completion

2026-09-30

Completion

2026-09-30

Drugs

Indications